SEPTIN6-Related Congenital Neutropenia and B Cell Deficiency

Congenital Neutropenia
DOI: 10.70962/cis2025abstract.15 Publication Date: 2025-04-25T20:15:14Z
ABSTRACT
Septins, a highly conserved family of GTP-binding, filament-forming proteins, serve as scaffolds and diffusion barriers in various cellular processes. SEPTIN6 is involved hematopoiesis, assisting cell division cytokinesis. We present the second reported case SEPTIN6-related disease with X-linked congenital neutropenia, tetraploid precursors, multinucleated myeloid cells associated unique finding B deficiency abnormal initial NBS. A full-term male infant uncomplicated delivery screened positive on NBS for SCID. Labs showed moderate T (CD3+ 548 cells/µL) enumerated 90% CD45RA+, persistent profound (CD19+ 8 cells/µL), severe neutropenia (ANC < 200). NK were normal range. ADA testing was also normal. Repeat TRECs quantitation normalized by 2 months. Given absent circulating 1%), immunoglobulin replacement started. Peripheral smear decreased neutrophils intermittently multi-lobation granulation. Anti-neutrophil antibodies negative. Bone marrow (BM) biopsy at months normocellular maturing trilineage hematopoiesis hypersegmentation forms (neutrophils, monocytes, eosinophils), lymphoid cells. Neutropenia unresponsive to G-CSF vitamin B12 supplementation. At 4 months, BM enlarged, hypersegmented (up 80% tetraploidy), (<1%), rare CD79a+ (plasma cells). primary immunodeficiency genetic panel returned Research trio whole genome sequencing identified an maternally inherited variant SEPT6 c.1282T>A (p.*428Lysext*9). Sequential BMs increased reticular fibrosis, trisomy without overt dysplasia, markedly PAX5+CD20+ (<<1%) continued (<1%) morphologically similar plasma cells; matched-related donor transplant resulted full chimerism no acute or chronic GVHD 3 years post-transplant. Maternal demonstrated skewed X-inactivation locus. Mechanistic studies, including RNA-seq development assays, explore role development. Overall, we novel germline defect aplasia, case, successful outcome, remarkable similarity report disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....